Cited by 112Cholesterol and Lipid MetabolismDrug Transport and Resistance MechanismsPharmacogenetics and Drug Metabolism

Nuclear receptor-mediated repression of human cholesterol 7α-hydroxylase gene transcription by bile acids

Open access
Chen, Wenling, Owsley, Erika, Yang, Yizeng, Stroup, Diane, Chiang, John Y.L.·2001·Journal of Lipid Research

Abstract

Hydrophobic bile acids strongly repressed transcription of the human cholesterol 7alpha-hydroxylase gene (CYP7A1) in the bile acid biosynthetic pathway in the liver. Farnesoid X receptor (FXR) repressed CYP7A1/Luc reporter activity in a transfection assay in human liver-derived HepG2 cells, but not in human embryonic kidney (HEK) 293 cells. FXR-binding activity was required for bile acid repression of CYP7A1 transcription despite the fact that FXR did not bind to the CYP7A1 promoter. FXR-induced liver-specific factors must be required for mediating bile acid repression. Bile acids and FXR repressed endogenous CYP7A1 but stimulated alpha-fetoprotein transcription factor (FTF) and small heterodimer partner (SHP) mRNA expression in HepG2 cells. Feeding of rats with chenodeoxycholic acid repressed CYP7A1, induced FTF, but had no effect on SHP mRNA expression in the liver. FTF strongly repressed CYP7A1 transcription in a dose-dependent manner, and SHP further inhibited CYP7A1 in HepG2 cells, but not in HEK 293 cells. FXR only moderately stimulated SHP transcription, whereas FTF strongly inhibited SHP transcription in HepG2 cells. Results revealed that FTF was a dominant negative factor that was induced by bile acid-activated FXR to inhibit both CYP7A1 and SHP transcription. Differential regulation of FTF and SHP expression by bile acids may explain the wide variation in CYP7A1 expression and the rate of bile acid synthesis and regulation in different species.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0022-2275(20)30272-8

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 27 · Cited by 112

Authors
Chen, W., Owsley, E., Yang, Y., Stroup, D., & Chiang, J. Y. L.
Affiliations
Northeast Ohio Medical University (US)
Corresponding author
Chiang, John Y.L.
Venue
Journal of Lipid Research
Publisher
Elsevier BV
Published
2001-09
Volume
42
Issue
9
Pages
1402-1412
ISSN
0022-2275 (ISSN-L)
OpenAlex
W1862042053
Cited by
112
References
27
Citations by year
2026: 2 · 2025: 1 · 2024: 2 · 2023: 1 · 2022: 2 · 2021: 5 · 2020: 3 · 2019: 2 · 2018: 3 · 2017: 5 · 2016: 3 · 2015: 2 · 2014: 5 · 2013: 2 · 2012: 7
FWCI
8.27
Type
journal article
Language
en
Open access
Locations
  • Journal of Lipid Research (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Institutes of Health (5r01dk044442-26, 5r01gm031584-14, DK44442)
  • National Institute of General Medical Sciences (GM 31584)
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK44442, R01-DK-044442, R01DK058379)
Topics
  • Health Sciences › Medicine › Surgery › Cholesterol and Lipid Metabolism
  • Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
Keywords
CYP7A1, bile acids, farnesoid X receptor, transcriptional repression, small heterodimer partner, chenodeoxycholic acid, bile acid synthesis, hepatic gene regulation, dominant negative regulation
MeSH terms
Receptor, Farnesoid X-Activated, Animals, Bile Acids and Salts, Carrier Proteins, Cell Line, Cholesterol 7-alpha-Hydroxylase, DNA, DNA-Binding Proteins, Embryo, Mammalian, Cricetinae, Humans, Hydroxysteroid Dehydrogenases, Kidney, Liver, Luciferases, Membrane Glycoproteins, Promoter Regions, Genetic, Recombinant Fusion Proteins, RNA, Messenger, Taurocholic Acid, Transcription Factors, Transcription, Genetic, Transfection, Tumor Cells, Cultured, Gene Expression, CHO Cells, Receptors, Cytoplasmic and Nuclear, Receptors, Retinoic Acid, Caco-2 Cells, Reverse Transcriptase Polymerase Chain Reaction, 3-alpha-Hydroxysteroid Dehydrogenase (B-Specific), Retinoid X Receptors, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review